PT77213B - Pasteurisiertes human-fibrinogen (hf) verfahren zu dessen herstellung und dessen verwendung - Google Patents

Pasteurisiertes human-fibrinogen (hf) verfahren zu dessen herstellung und dessen verwendung

Info

Publication number
PT77213B
PT77213B PT77213A PT7721383A PT77213B PT 77213 B PT77213 B PT 77213B PT 77213 A PT77213 A PT 77213A PT 7721383 A PT7721383 A PT 7721383A PT 77213 B PT77213 B PT 77213B
Authority
PT
Portugal
Prior art keywords
fibrinogenic
production
pasteurized human
human fibrinogen
human
Prior art date
Application number
PT77213A
Other languages
German (de)
English (en)
Other versions
PT77213A (de
Original Assignee
Bedringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6171221&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT77213(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bedringwerke Ag filed Critical Bedringwerke Ag
Publication of PT77213A publication Critical patent/PT77213A/pt
Publication of PT77213B publication Critical patent/PT77213B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Ceramic Capacitors (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
PT77213A 1982-08-19 1983-08-17 Pasteurisiertes human-fibrinogen (hf) verfahren zu dessen herstellung und dessen verwendung PT77213B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3230849A DE3230849A1 (de) 1982-08-19 1982-08-19 Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung

Publications (2)

Publication Number Publication Date
PT77213A PT77213A (de) 1983-09-01
PT77213B true PT77213B (de) 1986-03-18

Family

ID=6171221

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77213A PT77213B (de) 1982-08-19 1983-08-17 Pasteurisiertes human-fibrinogen (hf) verfahren zu dessen herstellung und dessen verwendung

Country Status (14)

Country Link
US (1) US4960757A (pt)
EP (1) EP0103196B2 (pt)
JP (1) JPH0694419B2 (pt)
AT (1) ATE47525T1 (pt)
AU (1) AU587365B2 (pt)
CA (1) CA1203166A (pt)
DE (2) DE3230849A1 (pt)
ES (1) ES524992A0 (pt)
GR (1) GR78934B (pt)
IL (1) IL69515A (pt)
NO (1) NO159698C (pt)
NZ (1) NZ205306A (pt)
PT (1) PT77213B (pt)
ZA (1) ZA836093B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
AT390001B (de) * 1984-09-28 1990-03-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
JP2526073B2 (ja) * 1987-10-06 1996-08-21 株式会社ミドリ十字 異常破水治療剤
AT407834B (de) * 1987-10-08 2001-06-25 Aventis Behring Gmbh Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
FR2650508A1 (fr) 1989-08-01 1991-02-08 Fondation Nale Transfusion San Colle pasteurisee pour reunir des tissus humain ou animal
US5420250A (en) * 1990-08-06 1995-05-30 Fibrin Corporation Phase transfer process for producing native plasma protein concentrates
US5644032A (en) * 1990-08-06 1997-07-01 Fibrin Corporation Process for producing fibrinogen concentrates
DE4202667C1 (pt) * 1992-01-29 1993-05-13 Behringwerke Ag, 3550 Marburg, De
FR2687317B1 (fr) * 1992-02-13 1995-06-23 Aetsrn Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique.
US5385606A (en) * 1992-07-06 1995-01-31 Kowanko; Nicholas Adhesive composition and method
AU4693093A (en) * 1992-07-27 1994-02-14 Haemacure Biotech Inc. Biocompatible surgical implant
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
CA2185228A1 (en) * 1994-03-31 1995-10-12 John F. Lontz Cryoprecipitated native fibrinogen concentrates
JP5149470B2 (ja) 1999-02-22 2013-02-20 バクスター・インターナショナル・インコーポレイテッド 新規のアルブミンを含有していない第ｖｉｉｉ因子処方物
US6916911B1 (en) 1999-08-13 2005-07-12 Omrix Biopharmaceuticals Sa Use of fibrinogen multimers
WO2001012244A1 (en) * 1999-08-13 2001-02-22 Omrix Biopharmaceuticals S.A. Use of fibrinogen multimers
EP1240200B1 (en) * 1999-12-23 2009-06-03 Csl Limited Separation of fibrinogen from plasma proteases
JP4733283B2 (ja) * 2000-03-28 2011-07-27 一般財団法人化学及血清療法研究所 液状フィブリノゲン製剤
DE10022092A1 (de) * 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
DE10261126A1 (de) 2002-08-13 2004-03-04 Aventis Behring Gmbh Lagerungsstabile, flüssige Fibrinogen-Formulierung
DE102004009400A1 (de) * 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
DE102004037805B3 (de) * 2004-08-03 2006-03-23 Zlb Behring Gmbh Verfahren zur Hitzebehandlung fibrinogenhaltiger pharmazeutischer Zubereitungen
CA2742328C (en) 2008-11-07 2019-02-26 Baxter International Inc. Factor viii formulations
MX351340B (es) 2012-03-13 2017-10-11 Octapharma Ag Proceso mejorado para la produccion de fibrinogeno y fibrinogeno producido por este.
RU2556804C2 (ru) * 2013-12-17 2015-07-20 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения концентрата фибриногена

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate

Also Published As

Publication number Publication date
JPS5953428A (ja) 1984-03-28
NZ205306A (en) 1987-02-20
NO159698C (no) 1989-02-01
JPH0694419B2 (ja) 1994-11-24
DE3380764D1 (en) 1989-11-30
AU1810983A (en) 1984-02-23
NO159698B (no) 1988-10-24
GR78934B (pt) 1984-10-02
EP0103196B1 (de) 1989-10-25
IL69515A0 (en) 1983-11-30
ES8506450A1 (es) 1985-08-01
EP0103196A2 (de) 1984-03-21
CA1203166A (en) 1986-04-15
AU587365B2 (en) 1989-08-17
PT77213A (de) 1983-09-01
EP0103196A3 (en) 1985-05-08
US4960757A (en) 1990-10-02
ATE47525T1 (de) 1989-11-15
ZA836093B (en) 1984-04-25
IL69515A (en) 1987-01-30
NO832977L (no) 1984-02-20
DE3230849A1 (de) 1984-02-23
EP0103196B2 (de) 1994-10-12
ES524992A0 (es) 1985-08-01

Similar Documents

Publication Publication Date Title
PT77213B (de) Pasteurisiertes human-fibrinogen (hf) verfahren zu dessen herstellung und dessen verwendung
ATE24658T1 (de) Verfahren zur herstellung eines molkeproduktes.
PT77464A (de) Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipittat
IL76260A0 (en) Pasteurized,isoagglutinin-free factor viii preparation and process for its production
DE3583209D1 (de) Kontinuierliches verfahren zur herstellung von phosphorsaeure und von calciumsulfat.
DE3479086D1 (en) Method for the pasteurization of human plasma
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
ATE34747T1 (de) Verfahren zur herstellung von thiotetronsaeure.
ATE43342T1 (de) Verfahren zur herstellung von hydrogeno- oder halogenosilanen.
ATE42087T1 (de) Verfahren zur herstellung von dichtem wasserfreiem natriumcarbonat und nach diesem verfahren hergestelltes dichtes wasserfreies natriumcarbonat.
ZA885785B (en) Process for the preparation of n6-benzyloxycarbonyl-2,6-diaminopimelamic acid in the l,l or d,d or racemic forms
ATE8614T1 (de) Verfahren zur herstellung von 3,3dimethylglutars[ure.

Legal Events

Date Code Title Description
PC3A Transfer or assignment

Free format text: 980126 CENTEON PHARMA GMBH DE

PD3A Change of proprietorship

Owner name: AVENTIS BEHRING GMBH

Effective date: 20000316